Boston Scientific Corporation (BSX)
-NYSE 9.08 
0.08(0.87%) May 24, 4:00PM EDT|After Hours
:
9.09 0.01 (0.11%) May 24, 4:20PM EDT
| Prev Close: | 9.16 |
|---|
| Open: | 9.08 |
|---|
| Bid: | 9.08 x 100 |
|---|
| Ask: | 9.16 x 1300 |
|---|
| 1y Target Est: | 8.55 |
|---|
| Beta: | 1.24 |
|---|
| Next Earnings Date: | 24-Jul-13 |
|---|
| Day's Range: | 9.04 - 9.17 |
|---|
| 52wk Range: | 4.79 - 9.39 |
|---|
| Volume: | 18,912,195 |
|---|
| Avg Vol (3m): | 18,987,500 |
|---|
| Market Cap: | 12.26B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -3.28 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Ford Saves One Thousand Jobs In France and 2 More Heavily Traded Stocks to Followat Wall St. Cheat Sheet(Fri, May 24)
- St. Jude Begins EnligHTNment StudyZacks(Fri, May 24)
- Boston Scientific To Participate In The 38th Annual Deutsche Bank 2013 Healthcare ConferencePR Newswire(Fri, May 24)
- What Are Insiders Buying These Days?at Motley Fool(Thu, May 23)
- Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Ratesat Seeking Alpha(Thu, May 23)
- Boston Scientific’s Lotus Aortic Valve Has Promise in Studyat Bloomberg(Wed, May 22)
- BSX Entangled in Patent IssuesZacks(Wed, May 22)
- New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation SystemPR Newswire(Wed, May 22)
- Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargainat Investopedia(Wed, May 22)
- Boston Scientific says Lotus system met primary performance endpoint in trialtheflyonthewall.com(Wed, May 22)
- Boston Scientific Reports Lotus™ Valve System Met Primary Performance Endpoint in REPRISE II TrialPR Newswire(Wed, May 22)
- Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy DataPR Newswire(Wed, May 22)
- Medtronic Beats Earnings, Results StrongerZacks(Wed, May 22)
- 4 Healthcare Stock Stories For Tuesday Investment Wellnessat Wall St. Cheat Sheet(Tue, May 21)
- What's Behind Medtronic's 5% Pop?at Motley Fool(Tue, May 21)
Key Statistics
| Forward P/E (1 yr): | 19.32 |
|---|
| P/S (ttm): | 1.73 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.41 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.10 |
|---|
| Mean Recommendation*: | 2.5 |
|---|
| PEG Ratio (5 yr expected): | 2.32 |
|---|
Business Summary
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. The company offers interventional cardiology products, including coronary stent systems used in the tre...
View More